Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1.1
HKD
|
-1.79%
|
|
0.00%
|
-5.98%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,446
|
1,251
|
1,098
|
1,749
|
730.4
|
1,691
|
Enterprise Value (EV)
1 |
2,692
|
3,569
|
3,426
|
3,708
|
2,309
|
3,147
|
P/E ratio
|
-45.4
x
|
-18.1
x
|
-139
x
|
9.64
x
|
2.51
x
|
4.65
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.78
x
|
0.72
x
|
0.57
x
|
0.7
x
|
0.31
x
|
0.57
x
|
EV / Revenue
|
1.96
x
|
2.07
x
|
1.78
x
|
1.48
x
|
0.97
x
|
1.05
x
|
EV / EBITDA
|
-109
x
|
33
x
|
14.7
x
|
6.6
x
|
4.03
x
|
3.79
x
|
EV / FCF
|
-22.6
x
|
-21.7
x
|
20.4
x
|
11.9
x
|
3.96
x
|
8.39
x
|
FCF Yield
|
-4.42%
|
-4.61%
|
4.91%
|
8.43%
|
25.2%
|
11.9%
|
Price to Book
|
3.52
x
|
1.94
x
|
2.17
x
|
2.58
x
|
0.77
x
|
1.5
x
|
Nbr of stocks (in thousands)
|
1,592,079
|
1,590,324
|
1,590,324
|
1,590,324
|
1,590,324
|
1,590,324
|
Reference price
2 |
1.537
|
0.7864
|
0.6902
|
1.100
|
0.4593
|
1.063
|
Announcement Date
|
4/25/19
|
4/26/20
|
4/29/21
|
4/28/22
|
4/28/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,374
|
1,726
|
1,925
|
2,507
|
2,375
|
2,993
|
EBITDA
1 |
-24.7
|
108.2
|
233.4
|
561.7
|
572.6
|
830
|
EBIT
1 |
-146.8
|
-41.9
|
75.02
|
389.3
|
431.9
|
657.5
|
Operating Margin
|
-10.68%
|
-2.43%
|
3.9%
|
15.53%
|
18.19%
|
21.97%
|
Earnings before Tax (EBT)
1 |
-175.7
|
-168.2
|
-108.8
|
227.5
|
327.2
|
545.6
|
Net income
1 |
-53.84
|
-69.16
|
-7.876
|
181.6
|
290.8
|
363.8
|
Net margin
|
-3.92%
|
-4.01%
|
-0.41%
|
7.24%
|
12.24%
|
12.16%
|
EPS
2 |
-0.0338
|
-0.0435
|
-0.004952
|
0.1142
|
0.1829
|
0.2288
|
Free Cash Flow
1 |
-119
|
-164.7
|
168.3
|
312.8
|
582.5
|
375
|
FCF margin
|
-8.66%
|
-9.54%
|
8.74%
|
12.48%
|
24.53%
|
12.53%
|
FCF Conversion (EBITDA)
|
-
|
-
|
72.1%
|
55.68%
|
101.73%
|
45.18%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
172.28%
|
200.32%
|
103.07%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/25/19
|
4/26/20
|
4/29/21
|
4/28/22
|
4/28/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
245
|
2,318
|
2,329
|
1,959
|
1,578
|
1,455
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-9.936
x
|
21.42
x
|
9.976
x
|
3.487
x
|
2.757
x
|
1.753
x
|
Free Cash Flow
1 |
-119
|
-165
|
168
|
313
|
583
|
375
|
ROE (net income / shareholders' equity)
|
-16.6%
|
-26.9%
|
-20.7%
|
27.4%
|
32.6%
|
39.8%
|
ROA (Net income/ Total Assets)
|
-4.15%
|
-0.81%
|
1.13%
|
5.56%
|
5.93%
|
8.93%
|
Assets
1 |
1,299
|
8,497
|
-695.6
|
3,263
|
4,903
|
4,074
|
Book Value Per Share
2 |
0.4400
|
0.4100
|
0.3200
|
0.4300
|
0.6000
|
0.7100
|
Cash Flow per Share
2 |
0.3100
|
0.2100
|
0.3500
|
0.4800
|
0.4500
|
0.5100
|
Capex
1 |
299
|
314
|
367
|
325
|
310
|
339
|
Capex / Sales
|
21.74%
|
18.19%
|
19.06%
|
12.95%
|
13.05%
|
11.33%
|
Announcement Date
|
4/25/19
|
4/26/20
|
4/29/21
|
4/28/22
|
4/28/23
|
4/24/24
|
|
1st Jan change
|
Capi.
|
---|
| -5.98% | 223M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|